What is iPHEX Expo?

How IPHEX India is Driving India's Pharma Exports to the Next Level

India's pharmaceutical industry has earned global recognition as the “pharmacy of the world,” and one platform that plays a pivotal role in showcasing this potential is iPHEX—short for International Pharmaceuticals and Healthcare Exhibition. Organized by PHARMEXCIL (Pharmaceuticals Export Promotion Council of India) under the Ministry of Commerce and Industry, Government of India, iPHEX is more than just an exhibition—it's a global gateway to India’s pharmaceutical and healthcare sector.

🌍 What is iPHEX Expo?

iPHEX is an annual international exhibition that brings together the best of the Indian pharmaceutical industry, including:

• Formulations

• APIs (Active Pharmaceutical Ingredients)

• Ayush and Herbal products

• Medical devices

• Health services

• Biopharmaceuticals

• Nutraceuticals

  
  

With participation from over 500 Indian pharma companies and attendance from thousands of global buyers, regulatory officials, and healthcare professionals, iPHEX is a dynamic hub for B2B engagement, strategic collaborations, and global networking.

Held in different cities across India, this event provides a platform to display India's manufacturing strength, innovation, regulatory capabilities, and high-quality standards that meet global expectations.

🚀 How IPHEX India is Driving India's Pharma Exports to the Next Level

India’s pharma exports have seen remarkable growth over the last two decades, and iPHEX has played a catalytic role in propelling this trend. Here's how:

1. Connecting Indian Pharma with Global Markets

iPHEX connects Indian manufacturers directly with international buyers, government procurement agencies, health ministries, and drug regulatory authorities. This direct engagement has helped expand India's export footprint across more than 200 countries.

2. Promoting Quality & Regulatory Confidence

India’s pharma sector is known for being WHO-GMP compliant and approved by stringent global regulators like the USFDA, MHRA (UK), and EMA (Europe). iPHEX gives international delegates a first-hand look at India's quality standards, driving confidence in Indian products.

3. Encouraging Innovation & Diversification

The expo showcases not just generic medicines, but also biotech products, biosimilars, vaccines, and traditional medicines. This has helped Indian companies diversify their export offerings and tap into emerging markets with specific healthcare needs.

4. Boosting SME Participation

iPHEX provides a platform for small and medium enterprises (SMEs) to connect with global buyers—something they often struggle to do individually. By pooling resources and offering a collective platform, iPHEX boosts the visibility of SMEs and facilitates joint ventures and export contracts.

5. Strategic Focus on New Markets

With its Buyer-Seller Meets and Reverse Buyer Delegations, iPHEX focuses on expanding India's reach into non-traditional and under-penetrated markets such as Latin America, Africa, CIS countries, and Southeast Asia—helping India reduce dependency on mature markets.

6. Government-Backed Export Promotion

Being supported by PHARMEXCIL and the Government of India ensures that iPHEX receives both logistical support and policy attention. Trade delegations and incentives for exporters stemming from iPHEX discussions often translate into favorable trade policies and frameworks.

📈 iPHEX in Numbers

• Over 700 International Delegates attend every year

• Participation from 120+ countries

• Hosted more than 500 Indian exhibitors

• Facilitated billions of dollars in pharma exports over the years

  
  

🏁 Conclusion

iPHEX is more than just an event—it's a strategic national initiative. It reflects India’s ambition to lead in affordable healthcare and its strength in producing high-quality, cost-effective pharmaceuticals. With each edition, iPHEX helps bridge the gap between Indian manufacturers and global healthcare demands, driving export growth, trust, and long-term partnerships.

As the Indian pharma sector continues to evolve with advanced R&D, biosimilars, and specialty formulations, iPHEX is steering the industry toward the future—amplifying India’s voice on the global healthcare stage.

Are you a part of the pharma industry looking to expand globally?iPHEX might just be your launchpad.